2023
DOI: 10.3390/genes14081562
|View full text |Cite
|
Sign up to set email alerts
|

The Spectrum of the Heterozygous Effect in Biallelic Mendelian Diseases—The Symptomatic Heterozygote Issue

Kateryna Kalyta,
Weronika Stelmaszczyk,
Dominika Szczęśniak
et al.

Abstract: Heterozygous carriers of pathogenic/likely pathogenic variants in autosomal recessive disorders seem to be asymptomatic. However, in recent years, an increasing number of case reports have suggested that mild and unspecific symptoms can occur in some heterozygotes, as symptomatic heterozygotes have been identified across different disease types, including neurological, neuromuscular, hematological, and pulmonary diseases. The symptoms are usually milder in heterozygotes than in biallelic variants and occur “la… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 87 publications
(127 reference statements)
1
0
0
Order By: Relevance
“…The variant is most likely found in heterozygous state and we can presume that as such it can lead to structural alterations in neuronal cilia resulting in the development of dementia. This can be supported by many recent reports that have identified symptomatic heterozygotes with mild and unspecific symptoms, occurring later in life in many disorders, including neurological diseases [35].…”
Section: Discussionsupporting
confidence: 62%
“…The variant is most likely found in heterozygous state and we can presume that as such it can lead to structural alterations in neuronal cilia resulting in the development of dementia. This can be supported by many recent reports that have identified symptomatic heterozygotes with mild and unspecific symptoms, occurring later in life in many disorders, including neurological diseases [35].…”
Section: Discussionsupporting
confidence: 62%
“…Still, the detected ASS1 variants cause reduced argininosuccinate synthetase deficiency even in a heterozygous state, which then leads to increased ammonia levels exerting a toxic effect on the brain [46]. This can be supported by many recent reports that have identified symptomatic heterozygotes with mild and unspecific symptoms, occurring later in life in many disorders, including neurological diseases [47].…”
Section: Discussionmentioning
confidence: 83%